SEC Form 4 · accession 0000914190-26-000121
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hippel
Officer — CFO
Period of report
Aug 15, 2026
Accepted (ET)
Aug 18, 2026 · 5:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2026 | M | 9,779 | $0.00 | A | 174,493 | D | |
| Common Stock | Aug 15, 2026 | F | 4,310 | $72.40 | D | 170,183 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Restricted Stock UnitsF2,F3 | — | Aug 15, 2026 | M | 866 | D | — | — | Common Stock | 866 | 12,999 | D |
| Performance Restricted Stock UnitsF2,F3 | — | Aug 15, 2026 | D | 12,999 | D | — | — | Common Stock | 12,999 | 0 | D |
| Performance Stock Options (Right to Buy)F4 | $84.61 | Aug 15, 2026 | D | 34,982 | D | — | Aug 15, 2030 | Common Stock | 34,982 | 2,332 | D |
| Restricted Stock UnitsF2,F7 | — | Aug 15, 2026 | M | 4,010 | D | — | — | Common Stock | 4,010 | 4,011 | D |
| Restricted Stock UnitsF2,F11 | — | Aug 15, 2026 | M | 4,903 | D | — | — | Common Stock | 4,903 | 9,807 | D |
| Stock Options (Right to Buy)F1 | $66.97 | holding | — | — | — | — | Aug 5, 2027 | Common Stock | 167,328 | 167,328 | D |
| Stock Options (Right to Buy)F1 | $120.46 | holding | — | — | — | — | Aug 6, 2028 | Common Stock | 40,536 | 40,536 | D |
| Stock Options (Right to Buy)F1 | $94.52 | holding | — | — | — | — | Aug 15, 2029 | Common Stock | 45,220 | 45,220 | D |
| Stock Options (Right to Buy)F5 | $84.61 | holding | — | — | — | — | Aug 15, 2030 | Common Stock | 45,923 | 45,923 | D |
| Performance Restricted Stock UnitsF2,F6 | — | holding | — | — | — | — | — | Common Stock | 24,062 | 24,062 | D |
| Stock Options (Right to Buy)F8 | $74.91 | holding | — | — | — | — | Aug 15, 2034 | Common Stock | 32,417 | 32,417 | D |
| Restricted Stock UnitsF2,F9 | — | holding | — | — | — | — | — | Common Stock | 23,089 | 23,089 | D |
| Performance Restricted Stock UnitsF2,F10 | — | holding | — | — | — | — | — | Common Stock | 29,420 | 29,420 | D |
| Stock Options (Right to Buy)F12 | $53.60 | holding | — | — | — | — | Aug 15, 2035 | Common Stock | 37,632 | 37,632 | D |
Explanation of responses
- F1Fully exercisable.
- F10Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F114,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028.
- F12Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
- F2Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
- F3On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited.
- F4On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited.
- F5Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
- F6Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F74,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027.
- F8Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.
- F911,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.